Skip to main content
RYM
NASDAQ Life Sciences

RYTHM Reports Significant $6.62 Per Share Loss for Q4

feedReported by Dow Jones Newswires
Sentiment info
Negative
Importance info
8
Price
$17.1
Mkt Cap
$36.75M
52W Low
$13.22
52W High
$53.65
Market data snapshot near publication time

summarizeSummary

RYTHM announced a substantial fourth-quarter loss of $6.62 per share. This significant loss, particularly when viewed against the company's stock price and modest market capitalization, indicates a material financial underperformance. Professional traders would consider this a critical piece of new information, likely prompting a negative reaction in the stock price. Investors will now be keenly awaiting further details from management regarding the drivers of this loss and their outlook for future financial performance.

At the time of this announcement, RYM was trading at $17.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36.8M. The 52-week trading range was $13.22 to $53.65. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed RYM - Latest Insights

RYM
Apr 27, 2026, 6:06 AM EDT
Filing Type: DEFA14A
Importance Score:
8
RYM
Apr 27, 2026, 6:04 AM EDT
Filing Type: DEF 14A
Importance Score:
9
RYM
Apr 01, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
10
RYM
Mar 10, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
RYM
Mar 03, 2026, 4:21 PM EST
Source: Dow Jones Newswires
Importance Score:
8